Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study.
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Cetuximab; Gemcitabine
- Indications Biliary cancer
- Focus Therapeutic Use
- Acronyms ECHO
- 09 Feb 2011 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.
- 09 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2008 New trial record.